Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: J Pediatr. 2017 Nov 10;192:240–246.e1. doi: 10.1016/j.jpeds.2017.08.040

Table II.

Weighted prevalence of types of treatment currently and ever received (lifetime) by children and adolescents aged 4–17 years with current ADHD (NS-DATA 2014)

Currently receiving…
Lifetime…
Medication
School support*
Psychosocial treatments
Medication
School support*
Psychosocial treatments
% 95% CI % 95% CI % 95% CI % 95% CI % 95% CI % 95% CI
Overall 66.9 (63.5–70.2) 64.7 (61.4–68.0) 32.5 (29.2–36.0) 90.8 (88.4–92.7) 85.8 (83.2–88.0) 62.2 (58.8–65.5)
Sex
 Male 67.3 (63.2–71.3) 65.2 (61.2–69.0) 33.9 (29.9–38.1) 90.8 (87.8–93.1) 86.8 (83.8–89.3) 63.9 (59.9–67.8)
 Female 66.0 (59.6–71.9) 63.6 (57.3–69.6) 29.3 (23.7–35.5) 90.7 (86.2–93.8) 83.3 (77.8–87.6) 58.0 (51.7–64.1)
Age group
 4–11 y 76.1 (70.4–80.9) 71.7 (66.0–76.7) 44.7 (38.7–50.9) 88.5 (83.8–92.0) 85.8 (81.1–89.5) 69.6 (63.9–74.7)
 12–17y 62.3 (57.9–66.4) 61.2 (56.9–65.2) 26.1 (22.5–30.2) 91.9 (89.0–94.1) 85.7 (82.5–88.5) 58.4 (54.1–62.6)
Race
 White 69.2 (65.2–72.8) 63.3 (59.5–67.0) 29.5 (25.9–33.4) 93.3 (90.9–95.2) 84.0 (80.8–86.7) 59.6 (55.7–63.5)
 Black 61.6 (51.8–70.6) 68.0 (58.2–76.5) 44.8 (35.3–54.7) 83.3 (74.7–89.5) 89.4 (81.9–94.0) 65.2 (55.3–74.0)
 Multiracial/other 61.1 (50.2–70.9) 67.3 (56.5–76.6) 32.5 (23.4–43.1) 86.4 (77.2–92.2) 91.0 (83.0–95.4) 73.4 (63.6–81.3)
Ethnicity
 Non-Hispanic/Latino 68.8 (65.2–72.2) 64.6 (61.0–68.0) 31.4 (28.0–35.1) 92.3 (90.0–94.0) 85.0 (82.2–87.4) 60.6 (56.9–64.2)
 Hispanic/Latino 56.9 (46.2–67.0) 64.5 (53.8–73.9) 35.9 (26.2–46.9) 83.3 (73.1–90.1) 89.3 (79.9–94.6) 69.6 (59.4–78.1)
Primary language in the home
 English 67.5 (64.0–70.8) 64.3 (60.9–67.6) 31.6 (28.3–35.0) 91.6 (89.3–93.4) 85.3 (82.6–87.6) 61.7 (58.2–65.1)
 Any other language 50.8 (28.4–72.9) 76.9 (53.4–90.6) 61.1 (36.6–81.0) 68.4 (42.6–86.3) 99.9 (99.2–100.0) 76.7 (52.9–90.6)
Percentage of federal poverty level
 <100% 63.8 (55.9–71.0) 66.4 (58.4–73.5) 44.1 (36.3–52.2) 85.2 (78.7–90.0) 88.1 (81.7–92.4) 73.2 (65.5–79.7)
 100%-199% 63.6 (55.6–70.9) 66.2 (58.5–73.1) 34.8 (27.7–42.6) 92.2 (86.7–95.5) 85.7 (79.3–90.3) 62.9 (55.0–70.1)
 ≥200% 69.4 (64.9–73.6) 62.0 (57.6–66.3) 23.8 (20.2–27.8) 93.0 (90.0–95.1) 83.8 (80.1–86.9) 56.0 (51.4–60.4)
Any healthcare coverage
 Public insurance 67.9 (62.6–72.9) 68.7 (63.4–73.5) 41.9 (36.6–47.5) 89.7 (85.8–92.6) 87.9 (83.9–91.0) 70.1 (64.8–74.8)
 Private insurance 66.7 (62.0–71.0) 62.2 (57.7–66.5) 23.4 (19.7–27.6) 91.9 (88.6–94.3) 84.4 (80.8–87.4) 55.5 (50.9–60.0)
 Uninsured 48.6 (23.5–74.4) 36.1§ (17.1–60.8) 11.6 (4.1–29.0) 91.8 (77.6–97.3) 75.6 (43.3–92.6) 26.0§ (11.9–47.6)
Continuous insurance over past year
 No 45.4 (31.1–60.4) 59.0 (43.2–73.2) 27.2 (16.2–42.1) 86.9 (71.2–94.7) 82.2 (66.0–91.6) 51.2 (36.0–66.2)
 Yes 69.0 (65.5–72.3) 65.6 (62.1–68.9) 33.0 (29.6–36.7) 91.1 (88.6–93.0) 86.1 (83.5–88.4) 63.7 (60.2–67.1)
Receives care in a medical home
 No 64.8 (59.9–69.4) 69.5 (64.8–73.8) 36.7 (32.1–41.6) 89.9 (86.4–92.6) 89.9 (86.6–92.4) 68.8 (64.2–73.1)
 Yes 70.4 (65.3–75.0) 57.6 (52.4–62.6) 25.7 (21.3–30.7) 93.1 (89.8–95.3) 80.2 (75.6–84.0) 53.2 (48.0–58.4)
Region
 Northeast 67.5 (58.3–75.6) 71.3 (62.5–78.8) 36.7 (28.3–46.0) 87.2 (79.8–92.2) 85.9 (77.4–91.6) 65.8 (56.7–73.8)
 Midwest 69.0 (62.0–75.3) 68.1 (61.8–73.9) 38.2 (31.4–45.4) 94.9 (91.1–97.2) 87.0 (82.4–90.5) 61.9 (55.0–68.3)
 South 66.4 (60.9–71.5) 64.0 (58.7–69.1) 32.1 (27.1–37.6) 91.1 (87.0–94.0) 85.2 (81.1–88.6) 59.6 (54.1–64.8)
 West 65.1 (57.0–72.5) 56.6 (48.5–64.3) 22.9 (16.8–30.4) 87.7 (80.7–92.4) 85.4 (78.2–90.5) 65.9 (58.2–73.0)
Current ADHD severity
 Mild 53.8 (47.6–59.8) 53.9 (47.8–59.9) 21.3 (16.5–27.1) 84.9 (79.8–88.9) 83.0 (78.0–87.1) 51.1 (44.9–57.3)
 Moderate 69.7 (64.7–74.2) 65.8 (61.0–70.3) 34.3 (29.6–39.3) 92.5 (88.9–95.0) 84.9 (81.1–88.1) 65.5 (60.7–70.0)
 Severe 79.8 (71.7–86.0) 78.9 (70.5–85.3) 44.8 (36.7–53.2) 95.4 (89.9–97.9) 92.8 (86.2–96.4) 71.2 (62.7–78.5)
Age of diagnosis
 Before 6 y 73.3 (67.3–78.5) 72.2 (66.1–77.6) 47.5 (41.1–54.0) 91.7 (88.0–94.3) 88.6 (83.9–92.0) 74.7 (68.8–79.9)
 6–10 y 64.8 (60.1–69.1) 62.4 (57.9–66.6) 25.6 (21.8–29.9) 90.0 (86.4–92.7) 85.4 (81.9–88.4) 57.3 (52.7–61.7)
 11 y or older 59.5 (47.7–70.4) 52.7 (41.0–64.1) 23.1 (14.2–35.2) 92.2 (82.8–96.7) 76.1 (65.1–84.4) 49.1 (37.5–60.8)
Ever co-occurring condition**
 None 62.4 (55.1–69.1) 43.3 (36.5–50.3) 12.8 (8.6–18.6) 90.4 (84.9–94.0) 75.2 (68.6–80.8) 38.2 (31.6–45.3)
 Any 68.4 (64.4–72.1) 71.5 (67.7–74.9) 38.7 (34.8–42.8) 90.9 (88.1–93.1) 89.1 (86.3–91.3) 69.8 (65.9–73.3)
Current co-occurring condition**
 None 63.5 (57.6–69.0) 40.4 (35.0–46.1) 13.3 (9.7–18.0) 90.4 (86.0–93.5) 74.7 (69.3–79.4) 42.3 (36.7–48.1)
 Any 68.7 (64.4–72.8) 77.4 (73.6–80.8) 42.5 (38.2–47.0) 91.0 (87.9–93.3) 91.5 (88.8–93.7) 72.6 (68.5–76.4)

Bold = overall χ2 test was statistically significant (P < .05).

Underline = overall χ2 test approached statistical significance (.05 ≤ P < .10).

*

School supports include school-based educational support and/or classroom management.

Psychosocial treatments include peer interventions, social skills training, cognitive behavioral therapy, and/or parent training.

Subgroup classification data from 2011–2012 NSCH.

§

Estimate is unstable and may be unreliable. It has a relative SE between 30% and 50% and should be interpreted with caution.

Estimate is unreliable. It has a relative SE larger than 50% and should not be used except for inferential statistics (eg, comparisons with other estimates).

**

Co-occurring conditions included oppositional defiant disorder, conduct disorder, obsessive compulsive disorder, post-traumatic stress disorder, anxiety, bipolar disorder, other mood disorder such as depression, autism spectrum disorder or pervasive developmental disorder, sleep disorder, intellectual disability, learning disorder, language disorder, and/or tics.